Peptide-drug Conjugate Information
General Information of This Peptide-drug Conjugate (PDC)
| PDC ID |
PDC_00894
|
|||||
|---|---|---|---|---|---|---|
| PDC Name |
TAT-analogue 1 - Doxorubicin conjugate
|
|||||
| PDC Status |
Investigative
|
|||||
| Structure |
|
|||||
| Peptide Name |
TAT-analogue 1
|
Peptide Info | ||||
| Drug Name |
Doxorubicin
|
Drug Info | ||||
| Therapeutic Target |
DNA topoisomerase 2-alpha (TOP2A)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Peptide Modified Type |
Amino acid modifications
|
|||||
| Formula |
C128H199N43O35S
|
|||||
| #Ro5 Violations (Lipinski): 5 | Molecular Weight | 2932.333 | ||||
| Lipid-water partition coefficient (xlogp) | -15.0528 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 39 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 44 | |||||
| Rotatable Bond Count (rotbonds) | 88 | |||||